PB-CAG-DDdCas9VP192-T2A-GFP-IRES-Neo Citations (2)

Originally described in: Human pluripotent reprogramming with CRISPR activators.
Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti EM, Trokovic R, Kere J, Otonkoski T Nat Commun. 2018 Jul 6;9(1):2643. doi: 10.1038/s41467-018-05067-x. PubMed Journal

---

Articles Citing PB-CAG-DDdCas9VP192-T2A-GFP-IRES-Neo

Articles
Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter. Elbasani E, Falasco F, Gramolelli S, Nurminen V, Gunther T, Weltner J, Balboa D, Grundhoff A, Otonkoski T, Ojala PM. Viruses. 2020 Aug 27;12(9). pii: v12090952. doi: 10.3390/v12090952. PubMed
Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes. Rosengarten JF, Schatz S, Wolf T, Barbe S, Stitz J. Virology. 2022 Mar;568:41-48. doi: 10.1016/j.virol.2022.01.008. Epub 2022 Jan 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.